Pediatric Vaccines Market By Type, Technology and Application - Global Industry Analysis And Forecast To 2027
Published On : October 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC101363
Pediatric Vaccines Market By Type (Multivalent and Monovalent), Technology (Conjugate, Live Attenuated, Toxoid, Subunit, Inactivated and Others) and Application (Allergy, Cancer and Infectious Disease) - Global Industry Analysis And Forecast To 2027
Industry Outlook
Pediatric is a branch of medicine that deals with medical care (diagnostics and treatments) of infants, children and adolescents. The word pediatrics means “healer of children”. Pediatric Vaccines use is growing due to factors like; reducing the healthcare spending, government’s initiatives to reduce the cost of patient’s immunization, rising number of vaccination programs, increase in development of new vaccines, increased presence of chronic disorders, etc. Therefore, the Pediatric Vaccines Market is anticipated to expand and has tremendous scope during the forecast period. The global Pediatric Vaccines Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Pediatric Vaccines Market is based on segment, by Type the market is segmented into Multivalent and Monovalent; by Technology the market is segmented into Conjugate, Live Attenuated, Toxoid, Subunit, Inactivated and Others; and by Application the market is segmented into Allergy, Cancer and Infectious Disease.
- Pediatric Vaccines Market, By Type
- Multivalent
- Monovalent
- Pediatric Vaccines Market, By Technology
- Conjugate
- Live Attenuated
- Toxoid
- Subunit
- Inactivated
- Others
- Pediatric Vaccines Market, By Application
- Allergy
- Cancer
- Infectious Disease
Regional Insights
On a global front, the Pediatric Vaccines Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the global Pediatric Vaccines Market due to increasing government support and investment in R&D by leading companies.
Pediatric Vaccines Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Bio Med Pvt. Ltd., Sinovac Biotech Ltd., Mitsubishi Tanabe Pharma Corporation, Zydus Cadila, Pfizer Inc., GlaxoSmithKline plc., Serum Institute of India Pvt. Ltd., Merck Sharp & Dohme Corp., Indian Immunologicals Limited, Panacea Biotec, SANOFI and AstraZeneca. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Bio Med Pvt. Ltd.
- Sinovac Biotech Ltd.
- Mitsubishi Tanabe Pharma Corporation
- Zydus Cadila
- Pfizer Inc.
- GlaxoSmithKline plc.
- Serum Institute of India Pvt. Ltd.
- Merck Sharp & Dohme Corp.
- Indian Immunologicals Limited
- Panacea Biotec
- SANOFI
- AstraZeneca
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Pediatric Vaccines Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Multivalent
o Monovalent
· Pediatric Vaccines Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
o Conjugate
o Live Attenuated
o Toxoid
o Subunit
o Inactivated
o Others
· Pediatric Vaccines Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Allergy
o Cancer
o Infectious Disease
· Pediatric Vaccines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Pediatric Vaccines Market, By Country
o U.S. Pediatric Vaccines Market
o Canada Pediatric Vaccines Market
o Mexico Pediatric Vaccines Market
o Europe
§ Europe Pediatric Vaccines Market, By Country
o Germany Pediatric Vaccines Market
o UK Pediatric Vaccines Market
o France Pediatric Vaccines Market
o Russia Pediatric Vaccines Market
o Italy Pediatric Vaccines Market
o Rest of Europe Pediatric Vaccines Market
o Asia-Pacific
§ Asia-Pacific Pediatric Vaccines Market, By Country
o China Pediatric Vaccines Market
o Japan Pediatric Vaccines Market
o South Korea Pediatric Vaccines Market
o India Pediatric Vaccines Market
o Southeast Asia Pediatric Vaccines Market
o Rest of Asia-Pacific Pediatric Vaccines Market
o South America
§ South America Pediatric Vaccines Market, By Country
o Brazil Pediatric Vaccines Market
o Argentina Pediatric Vaccines Market
o Columbia Pediatric Vaccines Market
o Rest of South America Pediatric Vaccines Market
o Middle East and Africa
§ Middle East and Africa Pediatric Vaccines Market, By Country
o Saudi Arabia Pediatric Vaccines Market
o UAE Pediatric Vaccines Market
o Egypt Pediatric Vaccines Market
o Nigeria Pediatric Vaccines Market
o South Africa Pediatric Vaccines Market
o Rest of MEA Pediatric Vaccines Market
List of Tables
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2025)
4.1.2. Canada Market States and Outlook (2017-2025)
4.1.3. Mexico Market States and Outlook (2017-2025)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2025)
4.2.2. France Market States and Outlook (2017-2025)
4.2.3. UK Market States and Outlook (2017-2025)
4.2.4. Russia Market States and Outlook (2017-2025)
4.2.5. Italy Market States and Outlook (2017-2025)
4.2.6. Rest of Europe Market States and Outlook (2017-2025)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2025)
4.3.2. Japan Market States and Outlook (2017-2025)
4.3.3. Korea Market States and Outlook (2017-2025)
4.3.4. India Market States and Outlook (2017-2025)
4.3.5. Southeast Asia Market States and Outlook (2017-2025)
4.3.6. Rest of Asia-Pacific Market States and Outlook (2017-2025)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2025)
4.4.2. Argentina Market States and Outlook (2017-2025)
4.4.3. Columbia Market States and Outlook (2017-2025)
4.4.4. Rest of South America Market States and Outlook (2017-2025)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2025)
4.5.2. United Arab Emirates Market States and Outlook (2017-2025)
4.5.3. Egypt Market States and Outlook (2017-2025)
4.5.4. Nigeria Market States and Outlook (2017-2025)
4.5.5. South Africa Market States and Outlook (2017-2025)
4.5.6. Turkey Market States and Outlook (2017-2025)
4.5.7. Rest of Middle East and Africa Market States and Outlook (2017-2025)
5. Pediatric Vaccines Market, By Type
5.1. Introduction
5.2. Global Pediatric Vaccines Revenue and Market Share by Type (2017-2018)
5.2.1. Global Pediatric Vaccines Revenue and Revenue Share by Type (2017-2018)
5.3. Multivalent
5.3.1. Global Multivalent Revenue and Growth Rate (2017-2018)
5.4. Monovalent
5.4.1. Global Monovalent Revenue and Growth Rate (2017-2018)
6. Pediatric Vaccines Market, By Technology
6.1. Introduction
6.2. Global Pediatric Vaccines Revenue and Market Share by Technology (2017-2018)
6.2.1. Global Pediatric Vaccines Revenue and Revenue Share by Technology (2017-2018)
6.3. Conjugate
6.3.1. Global Conjugate Revenue and Growth Rate (2017-2018)
6.4. Live Attenuated
6.4.1. Global Live Attenuated Revenue and Growth Rate (2017-2018)
6.5. Toxoid
6.5.1. Global Toxoid Revenue and Growth Rate (2017-2018)
6.6. Subunit
6.6.1. Global Subunit Revenue and Growth Rate (2017-2018)
6.7. Inactivated
6.7.1. Global Inactivated Revenue and Growth Rate (2017-2018)
6.8. Others
6.8.1. Global Others Revenue and Growth Rate (2017-2018)
7. Pediatric Vaccines Market, By Application
7.1. Introduction
7.2. Global Pediatric Vaccines Revenue and Market Share by Application (2017-2018)
7.2.1. Global Pediatric Vaccines Revenue and Revenue Share by Application (2017-2018)
7.3. Allergy
7.3.1. Global Allergy Revenue and Growth Rate (2017-2018)
7.4. Cancer
7.4.1. Global Cancer Revenue and Growth Rate (2017-2018)
7.5. Infectious Disease
7.5.1. Global Infectious Disease Revenue and Growth Rate (2017-2018)
8. Pediatric Vaccines Market, By Region
8.1. Introduction
8.2. Global Pediatric Vaccines Revenue and Market Share by Regions
8.2.1. Global Pediatric Vaccines Revenue by Regions (2017-2018)
8.3. North America Pediatric Vaccines by Countries
8.3.1. North America Pediatric Vaccines Revenue and Growth Rate (2017-2018)
8.3.2. North America Pediatric Vaccines Revenue (Million USD) by Countries (2017-2018)
8.3.3. United States
8.3.3.1. United States Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.3.4. Canada
8.3.4.1. Canada Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.3.5. Mexico
8.3.5.1. Mexico Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.4. Europe Pediatric Vaccines by Countries
8.4.1. Europe Pediatric Vaccines Revenue and Growth Rate (2017-2018)
8.4.2. Europe Pediatric Vaccines Revenue (Million USD) by Countries (2017-2018)
8.4.3. Germany
8.4.3.1. Germany Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.4.4. France
8.4.4.1. France Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.4.5. UK
8.4.5.1. UK Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.4.6. Russia
8.4.6.1. Russia Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.4.7. Italy
8.4.7.1. Italy Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.5. Asia-Pacific Pediatric Vaccines by Countries
8.5.1. Asia-Pacific Pediatric Vaccines Revenue and Growth Rate (2017-2018)
8.5.2. Asia-Pacific Pediatric Vaccines Revenue (Million USD) by Countries (2017-2018)
8.5.3. China
8.5.3.1. China Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.5.4. Japan
8.5.4.1. Japan Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.5.5. Korea
8.5.5.1. Korea Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.5.6. India
8.5.6.1. India Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.6. South America Pediatric Vaccines by Countries
8.6.1. South America Pediatric Vaccines Revenue and Growth Rate (2017-2018)
8.6.2. South America Pediatric Vaccines Revenue (Million USD) by Countries (2017-2018)
8.6.3. Brazil
8.6.3.1. Brazil Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.6.4. Argentina
8.6.4.1. Argentina Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.6.5. Columbia
8.6.5.1. Columbia Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.7. Middle East and Africa Pediatric Vaccines by Countries
8.7.1. Middle East and Africa Pediatric Vaccines Revenue and Growth Rate (2017-2018)
8.7.2. Middle East and Africa Pediatric Vaccines Revenue (Million USD) by Countries (2017-2018)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.7.5. Egypt
8.7.5.1. Egypt Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.7.6. Nigeria
8.7.6.1. Nigeria Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.7.7. South Africa
8.7.7.1. South Africa Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.7.8. Turkey
8.7.8.1. Turkey Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
9. Company Profiles
9.1. Bio Med Pvt. Ltd.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Sinovac Biotech Ltd.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Mitsubishi Tanabe Pharma Corporation
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Zydus Cadila
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Pfizer Inc.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. GlaxoSmithKline plc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Serum Institute of India Pvt. Ltd.
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Merck Sharp & Dohme Corp.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Indian Immunologicals Limited
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. Panacea Biotec
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
9.11. SANOFI
9.11.1. Business Overview
9.11.2. Service Portfolio
9.11.3. Strategic Developments
9.11.4. Revenue and Market Share
9.12. AstraZeneca
9.12.1. Business Overview
9.12.2. Service Portfolio
9.12.3. Strategic Developments
9.12.4. Revenue and Market Share
10. Global Pediatric Vaccines Market Competition, by Manufacturer
10.1. Global Pediatric Vaccines Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Pediatric Vaccines Price By Region (2017-2017)
10.3. Top 5 Pediatric Vaccines Manufacturer Market Share
10.4. Market Competition Trend
11. Pediatric Vaccines Market Forecast (2018-2025)
11.1. Global Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2018-2025)
11.2. Pediatric Vaccines Market Forecast by Regions (2018-2025)
11.2.1. North America Pediatric Vaccines Market Forecast (2018-2025)
11.2.1.1. United States Pediatric Vaccines Market Forecast (2018-2025)
11.2.1.2. Canada Pediatric Vaccines Market Forecast (2018-2025)
11.2.1.3. Mexico Pediatric Vaccines Market Forecast (2018-2025)
11.2.2. Europe Pediatric Vaccines Market Forecast (2018-2025)
11.2.2.1. Germany Pediatric Vaccines Market Forecast (2018-2025)
11.2.2.2. France Pediatric Vaccines Market Forecast (2018-2025)
11.2.2.3. UK Pediatric Vaccines Market Forecast (2018-2025)
11.2.2.4. Russia Pediatric Vaccines Market Forecast (2018-2025)
11.2.2.5. Italy Pediatric Vaccines Market Forecast (2018-2025)
11.2.2.6. Rest of Europe Pediatric Vaccines Market Forecast (2018-2025)
11.2.3. Asia-Pacific Pediatric Vaccines Market Forecast (2018-2025)
11.2.3.1. China Pediatric Vaccines Market Forecast (2018-2025)
11.2.3.2. Japan Pediatric Vaccines Market Forecast (2018-2025)
11.2.3.3. Korea Pediatric Vaccines Market Forecast (2018-2025)
11.2.3.4. India Pediatric Vaccines Market Forecast (2018-2025)
11.2.3.5. Southeast Asia Pediatric Vaccines Market Forecast (2018-2025)
11.2.3.6. Rest of Asia-Pacific Pediatric Vaccines Market Forecast (2018-2025)
11.2.4. South America Pediatric Vaccines Market Forecast (2018-2025)
11.2.4.1. Brazil Pediatric Vaccines Market Forecast (2018-2025)
11.2.4.2. Argentina Pediatric Vaccines Market Forecast (2018-2025)
11.2.4.3. Columbia Pediatric Vaccines Market Forecast (2018-2025)
11.2.4.4. Rest of South America Pediatric Vaccines Market Forecast (2018-2025)
11.2.5. Middle East and Africa Pediatric Vaccines Market Forecast (2018-2025)
11.2.5.1. Saudi Arabia Pediatric Vaccines Market Forecast (2018-2025)
11.2.5.2. United Arab Emirates Pediatric Vaccines Market Forecast (2018-2025)
11.2.5.3. Egypt Pediatric Vaccines Market Forecast (2018-2025)
11.2.5.4. Nigeria Pediatric Vaccines Market Forecast (2018-2025)
11.2.5.5. South Africa Pediatric Vaccines Market Forecast (2018-2025)
11.2.5.6. Turkey Pediatric Vaccines Market Forecast (2018-2025)
11.2.5.7. Rest of Middle East and Africa Pediatric Vaccines Market Forecast (2018-2025)
11.3. Pediatric Vaccines Market Forecast by Type (2018-2025)
11.3.1. Pediatric Vaccines Forecast by Type (2018-2025)
11.3.2. Pediatric Vaccines Market Share Forecast by Type (2018-2025)
11.4. Pediatric Vaccines Market Forecast by Technology (2018-2025)
11.4.1. Pediatric Vaccines Forecast by Technology (2018-2025)
11.4.2. Pediatric Vaccines Market Share Forecast by Technology (2018-2025)
11.5. Pediatric Vaccines Market Forecast by Application (2018-2025)
11.5.1. Pediatric Vaccines Forecast by Application (2018-2025)
11.5.2. Pediatric Vaccines Market Share Forecast by Application (2018-2025)
List of Figures
List of Tables and Figures
Figure United States Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Pediatric Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Pediatric Vaccines Revenue and Revenue Share by Type (2017-2018)
Figure Global Multivalent Revenue and Growth Rate (2017-2018)
Figure Global Monovalent Revenue and Growth Rate (2017-2018)
Table Global Pediatric Vaccines Revenue and Revenue Share by Technology (2017-2018)
Figure Global Conjugate Revenue and Growth Rate (2017-2018)
Figure Global Live Attenuated Revenue and Growth Rate (2017-2018)
Figure Global Toxoid Revenue and Growth Rate (2017-2018)
Figure Global Subunit Revenue and Growth Rate (2017-2018)
Figure Global Inactivated Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Pediatric Vaccines Revenue and Revenue Share by Application (2017-2018)
Figure Global Allergy Revenue and Growth Rate (2017-2018)
Figure Global Cancer Revenue and Growth Rate (2017-2018)
Figure Global Infectious Disease Revenue and Growth Rate (2017-2018)
Table Global Pediatric Vaccines Revenue by Regions (2017-2018)
Figure North America Pediatric Vaccines Growth Rate (2017-2018)
Figure North America Pediatric Vaccines Revenue and Growth Rate (2017-2018)
Figure North America Pediatric Vaccines by Countries (2017-2018)
Figure North America Pediatric Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure United States Pediatric Vaccines Growth Rate (2017-2018)
Figure United States Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Pediatric Vaccines Growth Rate (2017-2018)
Figure Canada Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Pediatric Vaccines Growth Rate (2017-2018)
Figure Mexico Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Pediatric Vaccines Growth Rate (2017-2018)
Figure Europe Pediatric Vaccines Revenue and Growth Rate (2017-2018)
Figure Europe Pediatric Vaccines by Countries (2017-2018)
Figure Europe Pediatric Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Germany Pediatric Vaccines Growth Rate (2017-2018)
Figure Germany Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Pediatric Vaccines Growth Rate (2017-2018)
Figure France Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Pediatric Vaccines Growth Rate (2017-2018)
Figure UK Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Pediatric Vaccines Growth Rate (2017-2018)
Figure Russia Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Pediatric Vaccines Growth Rate (2017-2018)
Figure Italy Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Pediatric Vaccines Growth Rate (2017-2018)
Figure Rest of Europe Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Pediatric Vaccines Growth Rate (2017-2018)
Figure Asia-Pacific Pediatric Vaccines Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Pediatric Vaccines by Countries (2017-2018)
Figure Asia-Pacific Pediatric Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure China Pediatric Vaccines Growth Rate (2017-2018)
Figure China Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Pediatric Vaccines Growth Rate (2017-2018)
Figure Japan Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Pediatric Vaccines Growth Rate (2017-2018)
Figure Korea Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Pediatric Vaccines Growth Rate (2017-2018)
Figure India Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Pediatric Vaccines Growth Rate (2017-2018)
Figure Southeast Asia Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Pediatric Vaccines Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Pediatric Vaccines Growth Rate (2017-2018)
Figure South America Pediatric Vaccines Revenue and Growth Rate (2017-2018)
Figure South America Pediatric Vaccines by Countries (2017-2018)
Figure South America Pediatric Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Pediatric Vaccines Growth Rate (2017-2018)
Figure Brazil Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Pediatric Vaccines Growth Rate (2017-2018)
Figure Argentina Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Pediatric Vaccines Growth Rate (2017-2018)
Figure Columbia Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Pediatric Vaccines Growth Rate (2017-2018)
Figure Rest of South America Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Pediatric Vaccines Growth Rate (2017-2018)
Figure Middle East and Africa Pediatric Vaccines Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Pediatric Vaccines by Countries (2017-2018)
Figure Middle East and Africa Pediatric Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Pediatric Vaccines Growth Rate (2017-2018)
Figure Saudi Arabia Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Pediatric Vaccines Growth Rate (2017-2018)
Figure United Arab Emirates Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Pediatric Vaccines Growth Rate (2017-2018)
Figure Egypt Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Pediatric Vaccines Growth Rate (2017-2018)
Figure Nigeria Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Pediatric Vaccines Growth Rate (2017-2018)
Figure South Africa Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Pediatric Vaccines Growth Rate (2017-2018)
Figure Turkey Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Pediatric Vaccines Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bio Med Pvt. Ltd. Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sinovac Biotech Ltd. Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mitsubishi Tanabe Pharma Corporation Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Zydus Cadila Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline plc. Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Serum Institute of India Pvt. Ltd. Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck Sharp & Dohme Corp. Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Indian Immunologicals Limited Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Panacea Biotec Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table SANOFI Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AstraZeneca Pediatric Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Pediatric Vaccines Market Share by Manufacturer
Figure Global Pediatric Vaccines Revenue and Market Share by Manufacturer
Table Global Pediatric Vaccines Price by Region (2017-2017)
Figure Top 5 Pediatric Vaccines Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Pediatric Vaccines Revenue (Millions USD) and Growth Rate (2018-2025)
Table Pediatric Vaccines Market Forecast by Regions (2018-2025)
Figure North America Pediatric Vaccines Market Forecast (2018-2025)
Figure United States Pediatric Vaccines Market Forecast (2018-2025)
Figure Canada Pediatric Vaccines Market Forecast (2018-2025)
Figure Mexico Pediatric Vaccines Market Forecast (2018-2025)
Figure Europe Pediatric Vaccines Market Forecast (2018-2025)
Figure Germany Pediatric Vaccines Market Forecast (2018-2025)
Figure France Pediatric Vaccines Market Forecast (2018-2025)
Figure UK Pediatric Vaccines Market Forecast (2018-2025)
Figure Russia Pediatric Vaccines Market Forecast (2018-2025)
Figure Italy Pediatric Vaccines Market Forecast (2018-2025)
Figure Rest of Europe Pediatric Vaccines Market Forecast (2018-2025)
Figure Asia-Pacific Pediatric Vaccines Market Forecast (2018-2025)
Figure China Pediatric Vaccines Market Forecast (2018-2025)
Figure Japan Pediatric Vaccines Market Forecast (2018-2025)
Figure Korea Pediatric Vaccines Market Forecast (2018-2025)
Figure India Pediatric Vaccines Market Forecast (2018-2025)
Figure Southeast Asia Pediatric Vaccines Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Pediatric Vaccines Market Forecast (2018-2025)
Figure South America Pediatric Vaccines Market Forecast (2018-2025)
Figure Brazil Pediatric Vaccines Market Forecast (2018-2025)
Figure Argentina Pediatric Vaccines Market Forecast (2018-2025)
Figure Columbia Pediatric Vaccines Market Forecast (2018-2025)
Figure Rest of South America Pediatric Vaccines Market Forecast (2018-2025)
Figure Middle East and Africa Pediatric Vaccines Market Forecast (2018-2025)
Figure Saudi Arabia Pediatric Vaccines Market Forecast (2018-2025)
Figure United Arab Emirates Pediatric Vaccines Market Forecast (2018-2025)
Figure Egypt Pediatric Vaccines Market Forecast (2018-2025)
Figure Nigeria Pediatric Vaccines Market Forecast (2018-2025)
Figure South Africa Pediatric Vaccines Market Forecast (2018-2025)
Figure Turkey Pediatric Vaccines Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Pediatric Vaccines Market Forecast (2018-2025)
Figure Global Pediatric Vaccines Forecast by Type (2018-2025)
Figure Global Pediatric Vaccines Market Share Forecast by Type (2018-2025)
Figure Global Pediatric Vaccines Forecast by Type (2018-2025)
Figure Global Pediatric Vaccines Forecast by Technology (2018-2025)
Figure Global Pediatric Vaccines Market Share Forecast by Technology (2018-2025)
Figure Global Pediatric Vaccines Forecast by Technology (2018-2025)
Figure Global Pediatric Vaccines Forecast by Application (2018-2025)
Figure Global Pediatric Vaccines Market Share Forecast by Application (2018-2025)
Figure Global Pediatric Vaccines Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|